Failed Back Surgery Syndrome (FBSS)
An analysis of the Washington State Department of Labor and Industries study of the effectiveness of spinal cord stimulation for workers' compensation patients with failed back surgery syndrome.
The long-term clinical studies that are summarized in this review have shown that spinal cord stimulation is effective in controlling pain associated with FBSS. The economic studies summarized here indicate that as compared to conventional medical management of patients with FBSS, spinal cord stimulation should become cost-effective after about 2 years of its use.
Long-term data from the PROCESS trial: Randomized controlled trial of spinal cord stimulation versus conventional medical management for failed back surgery syndrome.
A slide presentation summarizing the clinical and cost-effectiveness of spinal cord stimulation for failed back surgery syndrome.
Complex Regional Pain Syndrome (CRPS)
Analysis of the 5-year data from Kemler’s trial of spinal cord stimulation for complex regional pain syndrome.
The referenced long-term clinical studies have shown that spinal cord stimulation provides statistically significant pain relief in patients with CRPS. Economic studies show that as compared to the conventional medical management of patients with CRPS, spinal cord stimulation should become cost-effective after about 2 years of its use.
A slide presentation summarizing the clinical and cost-effectiveness of spinal cord stimulation for complex regional pain syndrome.
The National Institute for Health and Clinical Excellence (NICE) reviewed the available evidence for spinal cord stimulation for the treatment of chronic neuropathic pain as part of their health technology appraisal (HTA). All 403 patients included in the clinical studies assessed by NICE were implanted with Medtronic spinal cord neurostimulation systems.
Medtronic provides this information for your convenience only. It is not intended as a recommendation regarding clinical practice. It is the responsibility of the provider to determine coverage and submit appropriate codes, modifiers, and charges for the services rendered. This document provides assistance for FDA approved or cleared indications. Where reimbursement is requested for a use of a product that may be inconsistent, or not expressly specified in the FDA cleared or approved labeling (e.g., instructions for use, operator’s manual, or package insert), consult with your billing advisors or payers for advice on handling such billing issues. Some payers may have policies that make it inappropriate to submit claims for such items or related service. Contact your Medicare contractor or other payer for interpretation of coverage, coding, and payment policies.